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Considerable effort has been focused on improving the control of size, shape, and surface modifications to detect proteins. The
purpose of this study was to compare the efficiencies of aminosilane-coated magnetite (As-M) nanoparticles (NPs), dextran-coated
magnetite nanoparticles (Dx-M), and bare nanoparticles for conjugating single-chain variable fragment antibodies (scFvs) with the
aim of detecting the human epidermal growth factor receptor 2 (HER2) protein. Dx-M and As-M NPs were characterized using
scanning electron microscopy, energy dispersive X-ray spectroscopy, X-ray diffraction, and Raman spectroscopy. Dx-M and As-M
were conjugated with a monoclonal scFv for active targeting of the HER2 antigen. Aminosilane surface coating enhanced the scFv
conjugation efficiency over twofold compared to that of the dextran-coated magnetite NPs for the detection of HER2 proteins.
1. Introduction
The development of nanomaterials has been widely touted as
a revolutionary paradigm shift for biological applications. In
recent years, considerable effort has been focused on improv-
ing the control of size, shape, and surface modifications to
gain better behavior as well as improved functionalization.
Magnetic nanoparticles (NPs) have become widely studied
due to the rapid increase in the number of applications in the
biomedical field, such as magnetic resonance imaging [1],
hyperthermia [2], drug delivery [3, 4], gene therapy [5, 6],
protein immobilization [7, 8], and immunoassay [9]. Among
other applications ofmagnetic NPs, for the immunoassay, the
conjugation of NPs with antibodies is the critical step and
severely limited by low efficiency of antibodies grafted on the
NP surface.
Although there has been significant work done on the
conjugation of chemically synthesized magnetite NPs to
antibodies [10–15] there have been relatively few studies
comparing the influence of antibody immobilizationmethod
in effectiveness of antigen detection. The conjugation of
the proteins with magnetic NPs can be done via physical
adsorption using polymer coatings, such as dextran, and
by covalent immobilization using amino derivatives, such
as aminosilane [3]. Dextran is a natural polysaccharide that
confers exceptionally high colloidal stability toNPs [16]. 3-(2-
aminoethylamino) propyltrimethoxysilane (APTES) is the
most frequently used compound to produce the aminosilane
coating to enhance protein adhesion [17–20]. Both dextran
and aminosilane have been used for the surface modification
of NPs to immobilize antibodies and to improve the disper-
sion of magnetite NPs. Despite the influence on dispersion
stability of the NPs, the type of coating has a remarkable
influence on the effectiveness of antibody immobilization.
The effectiveness of conjugation has an impact on the de-
tection of bioanalytes, such as cancer biomarkers. Overex-
pression of human epidermal growth factor receptor 2 (HER2)
is common to several types of human carcinomas [21–23], is
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involved in cell growth, and is a recognized biomarker for
breast cancer therapy [24–27].The aimof this study is to com-
pare aminosilane-coatedmagnetite (As-M)NPs and dextran-
coated magnetite (Dx-M) NPs conjugated with recom-
binant single-chain variable fragment antibodies (scFvs)
to Her2 (anti-HER2) through an adapted enzyme-linked
immunosorbent assay (ELISA) in order to choose the most
efficient scFv immobilizing agent.
2. Materials and Methods
2.1. Synthesis of Magnetite NPs. Magnetite NPs were synthe-
sized by alkaline coprecipitation of two equivalents of ferric
chloride (FeCl
3
⋅6H
2
O; Mallinckrodt) and one equivalent
of ferrous sulfate (FeSO
4
⋅7H
2
O; J.T.Baker) in 30% ammo-
nium hydroxide solution (NH
4
OH; J.T.Baker) with stirring.
The obtained precipitate was centrifuged at 6,000 rpm and
washed several times with distilled water until a pH ∼ 7
was reached. Finally, the precipitate was dried at 80∘C for 24
hours.
2.1.1. scFv Conjugation on Dx-M NPs. For the preparation of
Dx-M NPs, dextran (molecular weight 20,000Da) was dis-
solved in distilled water. FeCl
3
(0.01M) and FeSO
4
(0.005M)
were dispersed in 0.05% dextran solution. Synthesis of the
NPs was done as previously described. The products were
separated with a magnet and washed several times with
deionized water. Dx-M was resuspended in phosphate buffer
solution (pH 7.4). Then, 500𝜇L of Dx-M suspension and
500 𝜇L of scFvs were mixed by stirring gently and incubated
in a cold room at 4∘C for 24 hours. The products were
collected with a magnet and washed with buffer.
2.1.2. scFv Conjugation on As-M NPs. The obtained mag-
netite powder (200mg) was dispersed in 150mL of ethanol
and sonicated for 15 minutes, before the addition of
3-(2-aminoethylamino) propyltrimethoxysilane (AEPTMS,
Sigma-Aldrich). After ultrasonic agitation for 30min, the
suspended NPs were collected by magnetic decantation. The
precipitated product (As-M) was washed with ethanol five
times and dried at 80∘C for 24 hours. The As-M NPs were
resuspended in 1.0mL of 2% glutaraldehyde aqueous solution
with stirring for 4 hours at room temperature. Then, a
mixture of 500 𝜇L of As-M and 500 𝜇L of scFvs was added
and incubated in a cold room at 4∘C for 24 hours to allow
conjugation to take place. Finally, the solution was dialyzed
with phosphate buffered saline (PBS).
2.2. Characterization of NPs. The bare magnetite sample was
analyzed in PANalytical X’Pert MRD PRO device with a
Cu-k𝛼 source (𝜆 = 1.5406 A˚) operating at 40 kV and 30mA
and at a scanning rate of 0.1∘ 2𝜃s−1 from 10 to 80∘ 2𝜃.
Distances between peaks were compared to the International
Centre for Diffraction Data JCDPS, number 5-0664. The
average diffracting crystallite size of the prepared NPs was
calculated using Scherrer’s equation from the most intense
peak. Scanning electron microscopy (SEM) was performed
using a JEOL JSM6010LV/PLUS SEM to determine the
particle size and morphology of the magnetite nanoparticles.
For particle size analysis, the image processing software
Scandium was used and 100 particles were analyzed to cal-
culate the mean diameter ± standard deviation (SD). SEM
images were made with an accelerating voltage of 20 kV
and a working distance of 4 10mm. Energy dispersive X-
ray spectroscopy (EDS) using an Inca apparatus (Oxford
Instruments, Oxford, UK) was done for elemental analysis or
chemical characterization of the samples. TEM data was also
provided to confirm the chemically well-defined magnetite
nanoparticles. Hydrodynamic diameters and zeta potentials
were analyzed using a dynamic light scattering (DLS) (Nan-
otracWave,Microtrac) operating at 25∘C in a scattering angle
of 180∘; samples were suspended in Triton 2%, pH 7, and
sonicated 5minutes prior tomeasurement. Fourier transform
infrared spectra (FTIR) were recorded using a spectrome-
ter (Nicolet 6700/Thermo Electron) to identify functional
groups present in the surface-modified magnetite nanoparti-
cles. Infrared spectra with attenuated total reflection (ATR)
were recorded with a resolution of 4 cm−1 and the scan
range was set from 4000 to 600 cm−1. Raman spectra were
recorded in a WiTec system model Alpha 300 RA equipped
with a 785 nm laser source. Raman spectroscopy was used
to measure bands of -S-S-, -N-C-N-, and -C-S-, which are
likely to be found in proteins (scFvs). These groups are rich
in 𝜋-electron and, thus, have larger polarizability and totally
symmetric vibrational modes that are Raman active but may
not be infrared (IR) active and show no IR bands [28].
Because of these differences and considering that water, the
natural medium for proteins is a weak Raman scatter; Raman
was the method chosen for characterization of antibody-
NP conjugate. In addition, for proteins, studies focused on
investigating Raman spectra of proteins and the successful
design of NP probes has allowed advances in immunoassays
[29].
2.3. ELISA. Aliquots (50 𝜇L) of the homogenized suspen-
sions (scFv-Dx-M, scFv-As-M, and Dx-M) were deposited
on the bottom of wells in a 96well microplate. Next, a
permanent magnet was used to immobilize the conjugates
at the bottom. The plates were blocked with PBS containing
5% bovine serum albumin (BSA). Successively, anti-HA
antibody and horseradish peroxidase (HRP; GE Healthcare
Life Sciences) were added and incubated at 37∘C for 1 hour.
Unbound anti-HA was discarded by washing. All washing
steps were performed with 200𝜇L of PBS–0.05% Tween
20. Finally, 50𝜇L of 2,2󸀠-Azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid) (ABTS, Roche) was added and incubated for
15 minutes at room temperature and the absorbance was
read at 𝜆 = 405 nm in a Benchmark Plus device (Bio-Rad,
Hercules, CA, USA). Each independent experiment was run
in triplicate.
2.4. Statistical Analyses. Data are presented as the mean ±
standard deviation (SD). Differences between groups were
assessed by one-way analysis of variance (ANOVA) followed
by Tukey’s Multiple Comparison Analysis test. Values were
determined as significant when 𝑃 < 0.05.
Journal of Nanomaterials 3
(2 0 0)
(3 1 1)
(4 0 0)
(4 4 0)
(5 1 1)
(4 2 2)
10 20 30 40 50 60 70 80 900
2 
In
te
ns
ity
 (c
ou
nt
s)
Figure 1: XRD pattern for the magnetite (Fe
3
O
4
) nanoparticles.
3. Results and Discussion
The X-ray diffraction (XRD) pattern of uncoated magnetite
is shown in Figure 1, with the peaks corresponding to the
planes for (2 2 0), (3 1 1), (4 0 0), (4 2 2), (5 1 1), and (4 4
0); peaks are matched in position and in relative intensity to
the inverse spinel structure of magnetite pattern according
to JCPDS 5-0664. The average size of the crystallite was cal-
culated by the Scherrer equation [30–33], in which peak
width is inversely proportional to crystallite size.The average
crystallite size was 10.1 nm, which is consistent with the size
of superparamagnetic particles [34].
SEM revealed the morphological properties of the pre-
pared samples (Figure 2). Monodisperse magnetite NPs were
successfully synthesized.While a number of suitablemethods
have been developed for the synthesis of magnetic NPs,
the coprecipitation method yielded magnetite NPs with a
relatively uniform and spherical morphology with narrow
particle size distribution (8 ± 5 nm) according to SEM
measurements. The mean diameter of both coated particles
was around 20 nm. Furthermore, the EDS spectrum revealed
Fe and O in bare magnetite samples; Fe, O, and C in Dx-
M samples; and Fe, O, and Si in As-M samples, consistent
with the presence of aminosilane-modified NPs. In all the
samples, the carbon signal appeared due to the preparation
of the sample; however in Dx-M sample the signal was more
intense.
Representative TEM image with corresponding size dis-
tribution of magnetite nanoparticles is shown in Figure 3.
Well-defined nearly spherically shaped nanoparticles were
indeed obtained.Their average size, determined from the sta-
tistical sample of over one hundred nanoparticles, was found
to be 9.0 nm, while standard deviation of 2.3 nm indicated
a reasonably narrow size distribution. Moreover, notice the
accurate agreement between the average diameter assessed
from both XRD and TEM data confirming the presence of
monodomain nanoparticles.
Figure 4 shows the hydrodynamic size of M, As-M, and
Dx-M samples.The particle size, its distribution, and the sur-
face charge of Fe
3
O
4
are very important parameters not only
for modifying Fe
3
O
4
nanoparticles, but also for biomedical
applications.The coating of the nanoparticles can be evaluat-
ed by measuring the zeta potential. The results of the mean
hydrodynamic diameter, polydispersity index (PDI), and zeta
potential of the surface-modified magnetite nanoparticles
Table 1: Hydrodynamic diameter, polydispersity index, and zeta
potential of M, As-M, and Dx-M.
Sample HD, nm SD ZP, mV
M 4.97 1.64 −1.10
As-M 11.48 5.68 −23.10
Dx-M 7.47 2.31 −8.56
Abbreviations. M: magnetite nanoparticles; Dx-M: dextran-modified mag-
netite nanoparticles; As-M: AEPTMS-modified magnetite nanoparticles;
HD: hydrodynamic diameter; SD: standard deviation; ZP: zeta potential.
developed in this study are listed in Table 1. The smallest
hydrodynamic diameter of about 4.97±1.64 nmwas obtained
for bare magnetite nanoparticles. The mean particles size of
As-M and Dx-M was found to be11.48 ± 5.68, and 7.47 ±
2.31 nm, respectively, suggesting that the AEPTMS coating
did induce a significant increase of the mean particles size
(𝑃 < 0.05). Contrastingly, the coating with dextran did not
induced a significant increase of the particles diameter (𝑃 <
0.05). The zeta potential value obtained for M was slightly
negative (−1.10mV); this explains why magnetite nanoparti-
cles do not remain suspended for a long period of time. A zeta
potential of −23.10mV was observed for magnetite nanopar-
ticles coated with AEPTMS. Thus, the use of AEPTMS as a
coating also contributed to an increase in colloidal stability.
The zeta potential of Dx-M nanoparticles was −8.56mV,
which suggested that the nanoparticles weremainly stabilized
by steric repulsion.
The FTIR-ATR comparative spectra of bare and coated
Fe
3
O
4
nanoparticles, as well as the coating molecules, are
displayed in Figure 5. The samples that contain magnetite
(M, Dx-M, and As-M) clearly reveal the presence of strong
IR absorption band between 500 and 600 cm−1 character-
istic to the Fe-O vibration. IR spectra of pure AEPTMS
are shown in Figure 5(b) while the IR spectra of As-M
are shown in Figure 5(c). The IR spectrum of AEPTMS
exhibits absorptions at 2890 cm−1 and 1059 cm−1, which are
characteristic peaks of the stretching vibration of C-H and
Si-O, respectively. In the spectrum for As-M the peaks for
the functional group N-H and silane binding are marked.
A displacement of the Si-O peak is observed in the As-
M NPs. The peak found at 1383 cm−1 attributed to the
stretching vibrations of C-N bond, along with the band at
3360 cm−1 attributed to the H-N-H bending mode of free
amino groups, indicates that the AEPTMS has been grafted
onto the nanoparticles’ surface. In the same way, Figures 5(d)
and 5(e) give the IR absorption spectra of pure dextran and
Dx-M, respectively.The very broad band at 3380 cm−1 in both
Dx and Dx-M can be attributed to the stretching vibration of
O-H. The absorption bands at 2924 cm−1 can be ascribed to
the asymmetrical stretching vibration of C-H and the band
at 1008 cm−1 belongs to stretching vibrations of C-O-C bond
and glycosidic bridge. Regardless of the Fe-O band found in
Dx-M, very few differences can be found in the IR spectra of
Dx and Dx-Mwhich indicates that dextran coating occurs by
physical adsorption.
Nevertheless, to further evaluate the antibody Raman
spectroscopy was conducted. Raman spectra of the obtained
4 Journal of Nanomaterials
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Figure 2: SEM image and EDS analysis of (a) uncoated magnetite nanoparticles, (b) DX-M nanoparticles, and (c) As-M nanoparticles.
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Figure 3: TEM image of bare magnetite nanoparticles with image with corresponding size distribution.
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Figure 4: Particle size distribution of (a) magnetite, (b) AEPTMS-coated magnetite, and (c) dextran-coated magnetite.
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Figure 5: FTIR spectra of (a) magnetite, (b) AEPTMS, (c) aminosilane-coated magnetite, (d) dextran, and (e) dextran-coated magnetite.
materials are shown in Figure 6. According to the literature,
the modes present at 207, 392, and 470 cm−1 (Figure 6(a))
correspond to magnetite [35] and the band at near 1300 cm−1
is also attributable at magnetite [36, 37]. In the other sam-
ples, the spectral bands seen below 800 cm−1 are primar-
ily attributed to presence of magnetite [38] (Figures 6(b),
6(c), 6(e), and 6(f)). The Raman spectrum for the Dx-M
included the typical signals for the dextran and weak bands
typical of magnetite. For the Raman spectroscopy of the
Dx-M, the surface modification of dextran-coated magnetite
manifested in the electronic and vibrational properties of
the magnetite and resulted in the lowering of the energy
(Figure 6(b)). For aminosilane treated surfaces (Figure 6(c)),
the characteristic bands at 1117 cm−1 corresponded to Si-O-
C, 1348 cm−1 could be attributed to Csp3 bound with or
without heteroatoms, 1575 cm−1 was associated with bound
Csp2, and 3300 cm−1 was related to an amine group. The
results were consistent with the presence of aminosilane on
the surface of the magnetite NPs. Raman spectroscopy of
the antibody (Ab) soluble scFv (Figure 6(d)) was obtained.
The test solution contained 1 𝜇g/mL scFv diluted in PBS.
The Raman spectra scFv is typical of proteins [38, 39] with
bands associated with disulfide bonds (-S-S-, 544 cm−1),
polypeptide backbone (C𝛼-C, 940 cm−1), aromatic amino
acids (phenylalanine, tryptophan, and tyrosine, bands from
1000 to 1205 cm−1), C-H deformation (1325 and 1452 cm−1),
and amide III (1267 cm−1). The immobilization of the anti-
bodies in both conjugates Dx-M and As-M were consistent
with the Raman spectra of Dx-M-Ab (Figure 6(e)) and As-
M-Ab (Figure 6(f)); both exhibited bands characteristic of
the scFvs. The Raman spectrum for the Dx-M-Ab conjugates
included the typical signals for the dextran and weak bands
typical of proteins (amide I and phenylalanine aromatic ring
near at 1600 cm−1). The Raman band at ≈1550 cm−1 arises
from an indole ring vibration that is contributed mainly by
Trp in Dx-M-Ab and As-M-Ab samples [20].
The conjugated product was verified by ELISA using
a magnetic separator (Figure 7). Fifty microliters of the
homogenized suspensions (scFv-Dx-M, scFv-As-M, and Dx-
M) were used for ELISA using a magnet to immobilize the
conjugates (Figure 7) using HRP-conjugated anti-HA. The
ABTS assay is a colorimetric assay based on the ABTS cation
radical formation. The radical formation is catalyzed by the
reduction of HRP in the presence of H
2
O
2
. Employing this
assay, we are able to compare the absorbance generating
from the Dx-M-Ab and As-M-Ab conjugates and Dx-M
nonconjugate scFv (as the negative control) against a sec-
ondary anti-HA antibody. The 2-fold difference in ELISA
absorbance between scFv-AsM conjugates and scFv-DxM
was indicative of successful conjugation (Figure 8). Based on
the results of the evaluation of the ability of anti-HER2 scFv-
magnetite conjugate in binding anddetecting the studied pro-
tein, the chemical modification with aminosilane remarkably
improved the protein detection. In addition, the success of
binding to HER2 by As-M confirmed the existence of stable
chemical bonding between the NPs and antibody. This was
not evident in the Dx-Mmaterial whose modification occurs
primarily by physical adsorption. However, a considerable
difference was observed with respect to the first coating. The
results allowed us to infer that, despite the washes performed
on the aminosilane coating, the continuous antibody coupled
to the nanoparticles and was recognized by the secondary
anti-HA antibody. The results indicate that this coating is
suitable for this type of material bioconjugate.
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Figure 6: Comparative Raman spectra of (a) magnetite, (b) dextran-coated magnetite, (c) aminosilane-coated magnetite, (d) scFv antibody,
(e) scFv conjugated with dextran-coated magnetite, and (f) scFv conjugated with aminosilane-coated magnetite.
4. Conclusions
In this study, well-defined magnetite nanoparticles with a
narrow size distribution and coated with AEPTMS and dex-
tran were successfully obtained. Furthermore, zeta potential
measurements show that the magnetite nanoparticles coated
with AEPTMS or dextran are stable in aqueous suspension at
pH 7 which makes these nanomaterials suitable for biomed-
ical applications. Surface-modified magnetite nanoparticles
containing antibodies were prepared and their antigen recog-
nition ability toward HER2 as a model biomarker was
performed. We successfully used this nanomaterial to study
how coating changes the efficiency of antibody conjugation
and, consequently, how it also affects protein detection in
the magnetic bead ELISA. As-M NPs were more efficient in
scFv immobilization thanDx-MNPs conjugatedwith recom-
binant scFv anti-Her2. This strategy provides an alternative
approach to controlling surface functionalization with a view
to preparing high-efficiency receptor for specific proteins.
The immunoconjugate was proven to have a biomarker-
targeting activity. Such As-M might be very useful for
biomagnetically targeted detection in several types of human
carcinoma.
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All nanomaterial, except the As-M-antibody, has an absorbance
value < 0.20. Anti-HER2 scFv conjugated with As-M can detect
HER2 protein, with a 1.95-fold difference compared with Dx-M-
antibody. Dx-M (nonconjugate scFv) was used as the negative con-
trol. The results were obtained from triplicate determinations and
are expressed as mean ± SD.
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